Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cytarabine
Related studies linked through entity extraction aliases.
Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1
Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
- Status
- UNKNOWN
- Phase
- PHASE3
Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE3
Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3